156 related articles for article (PubMed ID: 34520152)
1. [Intravenous immunoglobulin in macrophage activation syndrome associated with systemic lupus erythematosus].
Mendoza-Álvarez SA; Galindo-López R; Sánchez-Escalona D; Velázquez-Santiago Y; Sánchez-Rodríguez AS
Rev Med Inst Mex Seguro Soc; 2020 Sep; 58(5):634-643. PubMed ID: 34520152
[TBL] [Abstract][Full Text] [Related]
2. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 20 Moroccan adult patients.
Wafa A; Hicham H; Naoufal R; Hajar K; Rachid R; Souad B; Mouna M; Zoubida MT; Mohamed A
Clin Rheumatol; 2022 Jul; 41(7):2021-2033. PubMed ID: 35179662
[TBL] [Abstract][Full Text] [Related]
3. Macrophage Activation Syndrome.
Sen ES; Clarke SL; Ramanan AV
Indian J Pediatr; 2016 Mar; 83(3):248-53. PubMed ID: 26400031
[TBL] [Abstract][Full Text] [Related]
4. Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report.
Gouda W; Alsaqabi F; Moshrif A; Abbas AS; Abdel-Aziz TM; Islam MA
J Med Case Rep; 2021 Oct; 15(1):497. PubMed ID: 34620236
[TBL] [Abstract][Full Text] [Related]
5. Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China.
Liu AC; Yang Y; Li MT; Jia Y; Chen S; Ye S; Zeng XZ; Wang Z; Zhao JX; Liu XY; Zhu J; Zhao Y; Zeng XF; Li ZG
Clin Rheumatol; 2018 Jan; 37(1):93-100. PubMed ID: 28409239
[TBL] [Abstract][Full Text] [Related]
6. Severe Bone Marrow Aplasia Following Macrophage Activation Syndrome in Systemic Lupus Erythematosus.
Ichimura H; Ichikawa S; Ono K; Inokura K; Hoshi Y; Shirai T; Fukuhara N; Yokoyama H; Fujii H; Harigae H
Tohoku J Exp Med; 2023 Aug; 260(4):301-304. PubMed ID: 37164698
[TBL] [Abstract][Full Text] [Related]
7. Hemophagocytosis in Cutaneous Autoimmune Disease.
Kerl K; Wolf IH; Cerroni L; Wolf P; French LE; Kerl H
Am J Dermatopathol; 2015 Jul; 37(7):539-43. PubMed ID: 25062264
[TBL] [Abstract][Full Text] [Related]
8. Unusual acute lupus hemophagocytic syndrome - a test of diagnostic criteria: a case report.
Wijetunga WMUA; Satarasinghe RL; Dayananda BM; Darshani GK
J Med Case Rep; 2017 Jul; 11(1):185. PubMed ID: 28683778
[TBL] [Abstract][Full Text] [Related]
9. Exploring Macrophage Activation Syndrome Secondary to Systemic Lupus Erythematosus in Adults: A Systematic Review of the Literature.
Aziz A; Castaneda EE; Ahmad N; Veerapalli H; Rockferry AG; Lankala CR; Hamid P
Cureus; 2021 Oct; 13(10):e18822. PubMed ID: 34804679
[TBL] [Abstract][Full Text] [Related]
10. Hemophagocytic syndrome as the initial manifestation of systemic lupus erythematosus.
Egües Dubuc CA; Uriarte Ecenarro M; Meneses Villalba C; Aldasoro Cáceres V; Hernando Rubio I; Belzunegui Otano J
Reumatol Clin; 2014; 10(5):321-4. PubMed ID: 24316336
[TBL] [Abstract][Full Text] [Related]
11. Macrophage activation syndrome in a patient with systemic lupus erythematosus (SLE) and dual viremia.
Awasthi S; Upreti S
J Community Hosp Intern Med Perspect; 2020 Sep; 10(5):470-474. PubMed ID: 33235686
[TBL] [Abstract][Full Text] [Related]
12. Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection.
Lorenz G; Schul L; Schraml F; Riedhammer KM; Einwächter H; Verbeek M; Slotta-Huspenina J; Schmaderer C; Küchle C; Heemann U; Moog P
Lupus; 2020 Mar; 29(3):324-333. PubMed ID: 32013725
[TBL] [Abstract][Full Text] [Related]
13. [The clinical characteristics of macrophage activation syndrome secondary to systemic lupus erythematosus].
Jiang N; Li MT; Wu D; Zeng XF
Zhonghua Nei Ke Za Zhi; 2016 Nov; 55(11):840-844. PubMed ID: 27801337
[No Abstract] [Full Text] [Related]
14. The Immunology of Macrophage Activation Syndrome.
Crayne CB; Albeituni S; Nichols KE; Cron RQ
Front Immunol; 2019; 10():119. PubMed ID: 30774631
[TBL] [Abstract][Full Text] [Related]
15. Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus.
Cohen EM; D'Silva K; Kreps D; Son MB; Costenbader KH
Lupus; 2018 Jun; 27(7):1065-1071. PubMed ID: 29451069
[TBL] [Abstract][Full Text] [Related]
16. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation.
Castillo L; Carcillo J
Pediatr Crit Care Med; 2009 May; 10(3):387-92. PubMed ID: 19325510
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of perforin in adult systemic lupus erythematosus associated macrophage activation syndrome: Clinicohematological correlation and literature review.
Velayutham B; Padhi S; Devi S; Patra S; Panigrahi C; Ramasubbu MK; Kumar R; Raheman S
Lupus; 2024 Jan; 33(1):26-39. PubMed ID: 38069452
[TBL] [Abstract][Full Text] [Related]
18. Distinct cytokine profile in juvenile systemic lupus erythematosus-associated macrophage activation syndrome.
Shimizu M; Yokoyama T; Tokuhisa Y; Ishikawa S; Sakakibara Y; Ueno K; Yachie A
Clin Immunol; 2013 Feb; 146(2):73-6. PubMed ID: 23291246
[TBL] [Abstract][Full Text] [Related]
19. Respiratory failure and macrophage activation syndrome as an onset of systemic lupus erythematosus: A case report.
Sun J; Wang JW; Wang R; Zhang H; Sun J
World J Clin Cases; 2019 Nov; 7(22):3859-3865. PubMed ID: 31799315
[TBL] [Abstract][Full Text] [Related]
20. Hemophagocytic syndrome as one of main manifestations in untreated systemic lupus erythematosus: two case reports and literature review.
Qian J; Yang CD
Clin Rheumatol; 2007 May; 26(5):807-10. PubMed ID: 16575493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
